Optinose Reports Third Quarter 2022 Financial Results and Operational Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ACCV
4. AZN
5. FICO
6. GMAB
7. QQQ
8. SPCX
9. APO
10. SMMT

Go back to Optinose Reports Third Quarter 2022 Financial Results and Operational Updates

Optinose (OPTN) PT Lowered to $5 at BMO Capital

November 11, 2022 8:53 AM EST

BMO Capital analyst Gary Nachman lowered the price target on Optinose (NASDAQ: OPTN) to $5.00 (from $6.00) while maintaining an Outperform rating.

The analyst commented, "3Q Xhance rev. missed by $3mm, but OPTN managed expenses offsetting that for in-line EPS. Xhance is facing some NT... More

OptiNose (OPTN) Tops Q3 EPS by 1c

November 10, 2022 7:56 AM EST

OptiNose (NASDAQ: OPTN) reported Q3 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $23.55 million.

GUIDANCE:

OptiNose sees Q4 2022 revenue of $74-78 million.

For earnings history and earnings-related data on OptiNose (OPTN) click here.

... More